---
pmid: '22306691'
title: The composition and signaling of the IL-35 receptor are unconventional.
authors:
- Collison LW
- Delgoffe GM
- Guy CS
- Vignali KM
- Chaturvedi V
- Fairweather D
- Satoskar AR
- Garcia KC
- Hunter CA
- Drake CG
- Murray PJ
- Vignali DA
journal: Nat Immunol
year: '2012'
full_text_available: false
pmcid: PMC3529151
doi: 10.1038/ni.2227
---

# The composition and signaling of the IL-35 receptor are unconventional.
**Authors:** Collison LW, Delgoffe GM, Guy CS, Vignali KM, Chaturvedi V, Fairweather D, Satoskar AR, Garcia KC, Hunter CA, Drake CG, Murray PJ, Vignali DA
**Journal:** Nat Immunol (2012)
**DOI:** [10.1038/ni.2227](https://doi.org/10.1038/ni.2227)
**PMC:** [PMC3529151](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3529151/)

## Abstract

1. Nat Immunol. 2012 Feb 5;13(3):290-9. doi: 10.1038/ni.2227.

The composition and signaling of the IL-35 receptor are unconventional.

Collison LW(1), Delgoffe GM, Guy CS, Vignali KM, Chaturvedi V, Fairweather D, 
Satoskar AR, Garcia KC, Hunter CA, Drake CG, Murray PJ, Vignali DA.

Author information:
(1)Department of Immunology, St. Jude Children's Research Hospital, Memphis, 
Tennessee, USA.

Interleukin 35 (IL-35) belongs to the IL-12 family of heterodimeric cytokines 
but has a distinct functional profile. IL-35 suppresses T cell proliferation and 
converts naive T cells into IL-35-producing induced regulatory T cells (iTr35 
cells). Here we found that IL-35 signaled through a unique heterodimer of 
receptor chains IL-12RÎ²2 and gp130 or homodimers of each chain. Conventional T 
cells were sensitive to IL-35-mediated suppression in the absence of one 
receptor chain but not both receptor chains, whereas signaling through both 
chains was required for IL-35 expression and conversion into iTr35 cells. 
Signaling through the IL-35 receptor required the transcription factors STAT1 
and STAT4, which formed a unique heterodimer that bound to distinct sites in the 
promoters of the genes encoding the IL-12 subunits p35 and Ebi3. This 
unconventional mode of signaling, distinct from that of other members of the 
IL-12 family, may broaden the spectrum and specificity of IL-35-mediated 
suppression.

DOI: 10.1038/ni.2227
PMCID: PMC3529151
PMID: 22306691 [Indexed for MEDLINE]

Conflict of interest statement: COMPETING FINANCIAL INTERESTS The authors 
declare competing financial interests. D.A.A.V., L.W.C. and K.M.V. have 
submitted patents that are pending and are entitled to a share in net income 
generated from licensing of these patent rights for commercial development. 
Furthermore, this work was supported in part by a sponsored research agreement 
with NovoNordisk to D.A.A.V.
